News

Press Releases

Views & Analysis

Newsletters and Deep Dive
digital magazine

Deep Dive

Market Access
Addressing Europe’s plasma deficit

Addressing Europe’s plasma deficit

Across the European Union approximately 300,000 patients with chronic conditions, such as haemophilia and severe immune-deficiency, depend on plasma-derived medicines, which can only be man

Webinars

Podcasts

Video

Market Access
Health Innovators – Aleks Engel

Health Innovators – Aleks Engel

One month ago, editor-in-chief Jonah Comstock travelled to Copenhagen, Denmark to visit the Novo Nordisk Foundation.

Market Access
Health Innovators – Søren Møller

Health Innovators – Søren Møller

Søren Møller, managing partner for seed investments at Novo Holdings, believes successful start-ups in healthcare share a trifecta of component pieces: “great science, the right talent, and

White Papers

Debates & Insight
PMA 2015 2016
Sponsored

Pricing & Market Access Outlook 2015/2016 Edition

Pricing and market access (P&MA) are key issues for the pharma industry as healthcare budgets continue to tighten and the value of innovative drugs, particularly in areas of high unmet need

Event

Market Access
Reuters Pharma Barcelona 2023 - Day 3

Reuters Pharma Barcelona 2023 - Day 3

Day Three arrives and Reuters Pharma 2023 comes to a close – but not before Boehringer Ingelheim talks to us about accelerating time-to-patient and an expert panel discusses empowering a wh

Market Access
Reuters Pharma USA 2023 - Live Coverage

Reuters Pharma USA 2023

On March 28th and 29th, industry leaders from across the pharmaceutical ecosystem will descend on Philadelphia for Reuters Pharma USA 2023.

Market Access
Reuters Pharma USA 2023 - Day 1

Reuters Pharma USA 2023 - Day 1

Thanks for joining us here in the City of Brotherly Love for the start of this year's Reuters Pharma USA conference.

Debates & Insight

Partner Content

Partner Content
Formedix-Clinical-MDR
Partner Content

Is there a faster way to build clinical trials?

As you know, clinical trials can be complex. Industry standards are now required for clinical trial submission. This means even more associated costs, resources, time, and effort.